318 results on '"Wilting, Saskia M"'
Search Results
2. Accurate detection of copy number aberrations in FFPE samples using the mFAST-SeqS approach
3. Integrative whole-genome and transcriptome analysis of HER2-amplified metastatic breast cancer
4. Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survival
5. Machine learning-based somatic variant calling in cell-free DNA of metastatic breast cancer patients using large NGS panels
6. Comprehensive characterization of circulating tumor cells and cell‐free DNA in patients with metastatic melanoma
7. Better prediction by use of co-data: Adaptive group-regularized ridge regression
8. Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and Differences
9. Circulating Tumour DNA as Biomarker for Colorectal Liver Metastases: A Systematic Review and Meta-Analysis
10. Author Correction: Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features
11. Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features
12. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments
13. The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies
14. Hypermethylation of DNA Methylation Markers in Non-Cirrhotic Hepatocellular Carcinoma
15. Liquid Biopsies for Colorectal Cancer and Advanced Adenoma Screening and Surveillance: What to Measure?
16. Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER Signaling
17. Liquid Biopsies for Early Response Evaluation of Radium-223 in Metastatic Prostate Cancer
18. mFast‐SeqS‐based aneuploidy score in circulating cell‐free DNA is a prognostic biomarker in prostate cancer
19. Machine learning-based somatic variant calling in cell-free DNA of metastatic breast cancer patients using large NGS panels
20. Abstract 5715: Circulating tumor DNA in colorectal cancer patients with resectable liver metastases: Preliminary results of the MIRACLE study
21. Supplementary Figures S1-S4 and Table S1 from Genome-wide DNA Methylation Profiling Reveals Methylation Markers Associated with 3q Gain for Detection of Cervical Precancer and Cancer
22. Supplementary Methods from Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples
23. Supplementary Figures and Tables from Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples
24. Supplementary Figure S2 from Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases
25. Abstract P2-03-14: Tumor-agnostic measurement of ctDNA levels in first line ER+, HER2- metastatic breast cancer patients as a marker for survival
26. Abstract P1-05-23: OPTIMIZING THE DIAGNOSIS OF LEPTOMENINGEAL METASTASES IN BREAST CANCER PATIENTS BY CIRCULATING TUMOR CELLS AND CIRCULATING TUMOR DNA
27. Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful Waiting
28. Cost-Effectiveness of Abemaciclib in Early Breast Cancer Patients: One Size Fits All or Tailoring to Patients’ Needs?
29. Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analyses
30. A pipeline for copy number profiling of single circulating tumour cells to assess intrapatient tumour heterogeneity
31. Gene length corrected trimmed mean of M-values (GeTMM) processing of RNA-seq data performs similarly in intersample analyses while improving intrasample comparisons
32. Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility study
33. ESR1 Methylation Measured in Cell-Free DNA to Evaluate Endocrine Resistance in Metastatic Breast Cancer Patients
34. Lost by Transcription: Fork Failures, Elevated Expression, and Clinical Consequences Related to Deletions in Metastatic Colorectal Cancer
35. Validity and utility of HER2/ERBB2 copy number variation assessed in liquid biopsies from breast cancer patients: A systematic review
36. Functional Screen for microRNAs Suppressing Anchorage-Independent Growth in Human Cervical Cancer Cells
37. Genome‐wide aneuploidy detected by mFast‐SeqS in circulating cell‐free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancer
38. Abstract P1-24-03: Clinicopathological characterization of inflammatory breast cancer in the Netherlands: First results of the prospective INFLAME registry
39. Abstract P2-01-17: Circulating tumor cell count and levels of circulating tumor DNA are complementary prognostic biomarkers in metastatic breast cancer - A pilot study
40. Pharmacological CDK4/6 inhibition reveals a p53‐dependent senescent state with restricted toxicity
41. A panel of DNA methylation markers for the classification of consensus molecular subtypes 2 and 3 in patients with colorectal cancer
42. High throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by Methylated DNA sequencing (MeD-seq) of LpnPI digested fragments
43. Genome-wide microRNA analysis of HPV-positive self-samples yields novel triage markers for early detection of cervical cancer
44. Genome‐wide microRNA analysis of HPV‐positive self‐samples yields novel triage markers for early detection of cervical cancer
45. Additional file 1 of High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments
46. Additional file 4 of High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments
47. Additional file 3 of High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments
48. Additional file 5 of High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments
49. Additional file 2 of High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments
50. Circular RNA in Chemonaive Lymph Node Negative Colon Cancer Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.